The week in health tech, explained in plain English.Get the free newsletter →
November 2, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Insurers Retreat From Medicare Advantage as Costs Climb

Several insurers are pulling out of Medicare Advantage markets or cutting back their plan offerings, a shift Becker's Hospital Review reports has accelerated over the past few years. The common thread is money: medical costs are climbing faster than expected, and federal cost-containment efforts have chipped away at the program's financial viability for carriers.

Star ratings are a central fault line. How the ratings are calculated determines which plans qualify for lucrative bonus payments, and ongoing disputes over that methodology have made revenue harder to predict. Layer on scrutiny of prior authorization denials and reimbursement pressure, and some insurers have decided certain markets are no longer worth serving, according to Becker's.

In practice, exits and plan reductions mean seniors in affected areas face fewer choices, potential coverage disruptions, and the hassle of switching plans. For hospitals and medical groups, a thinner MA field can reshape payer mix and contracting leverage. The retreat signals that the years of aggressive MA expansion are giving way to a more selective, margin-focused era.

More in Payers

Payers

How Health Plans Tell If Their Payment Ops Can Scale

Health plans can gauge whether their payment operations can truly scale by watching exception volume, return rates, and digital payment share as transaction counts rise.

Why it matters: Payment infrastructure that fails under growth drives up administrative costs and strains provider relationships just as a plan expands.

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.